Can-Fite BioPharma
CANF----
H2 2025 Earnings
Financial report interval: 2025.07.01 - 2025.12.31
Preview: Can-Fite BioPharma(CANF) predict that the Revenue is 203 K (--%), Beat estimate;the EBIT is -5.052 M (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B--
0.00B--
+0.00B--%
EBITExceed expectations
-0.01B--
-0.01B--
+0.00B--%
EPS
TBA--
0--
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf